The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review.
Rajanahally et al.·AndrologyImpact 2.5
GemischtGRADENiedrig67 Zitate
Stichprobek = 91 Studien
DauerLiteratur bis Mai 2017
EndpunktSamenparameter /…
Verblindungunklar
DesignSystematic Review
”Kernaussage
Cannabis zeigte inhibitorische Effekte auf Spermaparameter, gemischte Effekte auf sexuelle Funktion (mögliche Verbesserung subjektiven Empfindens, aber dosisabhängig ED-Risiko), und organabhängig unterschiedliche Effekte auf Malignität (erhöhtes Hodenkrebsrisiko, widersprüchliche Daten zu Blasenkrebs, anti-neoplastische Effekte bei Prostatakrebs).
Zusammenfassung
Systematische Review zu Cannabis und männlicher Urologie; k=91 Artikel (in vitro, Tiermodelle, Fallserien, Fall-Kontroll-/Kohorten-Studien), davon 25 zu urologischen Neoplasien. Cannabis-Exposition als unabhängiger Risikofaktor für Hodenkrebs identifiziert; widersprüchliche Daten zu Blasenkrebs; anti-neoplastische Effekte von Cannabinoiden bei Prostatakrebs berichtet.
P
PopulationMänner (v.a. junge Männer) mit Fokus auf Infertilität, sexuelle Gesundheit und urologische Neoplasien; 91 eingeschlossene Studien
I
InterventionCannabis-/Cannabinoid-Konsum (verschiedene Formen und Dosierungen)
Background: In the United States of America (USA), cannabis is legal in 28 states for medical purposes and 8 states for recreational use. In 2016, the legal Cannabis industry reached nearly $7 billion in sales in the USA alone. Although consumption continues to increase, the medical effects of Cannabis remain understudied. Young males comprise the demographic most likely to consume cannabis, and these individuals will be most vulnerable to its short- and long-term consequences.
Objective: The purpose of this manuscript is to systematically review the available literature describing the effects of Cannabis on male infertility, sexual health, and urologic neoplasms.
Materials And Methods: A comprehensive literature search was conducted using the Medline and Embase databases through May 2017. In vitro models, animal models, case series, case-control, and cohort designs were included. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement was utilized to report results.
Results: After exclusions, 91 articles were synthesized for qualitative analysis. Of these manuscripts, 30 pertained to Cannabis and male infertility, 36 discussed cannabis and male sexual health/hormones, and 25 explored the relationship between Cannabis and urologic neoplasms.
Discussion: With respect to male factor fertility using semen parameters as a surrogate, cannabinoids likely play an inhibitory role. Data on Cannabis and male sexual function are mixed but suggest that Cannabis may enhance the subjective experience of sexual intercourse while potentially contributing to ED in a dose-dependent manner. Cannabis has been associated with both increased and decreased risk of malignancy depending upon the target organ. Cannabis exposure seems to be an independent risk factor for testis cancer, data on bladder cancer are conflicting, and the evidence on prostate cancer supports anti-neoplastic effects of cannabinoids.
Conclusion: Studies of the effects of cannabis suggest impact on urologic health and disease. Prospective, long-term studies are necessary for further elucidation of these effects.